Cargando…
Evolution of Therapeutic Antibodies, Influenza Virus Biology, Influenza, and Influenza Immunotherapy
This narrative review article summarizes past and current technologies for generating antibodies for passive immunization/immunotherapy. Contemporary DNA and protein technologies have facilitated the development of engineered therapeutic monoclonal antibodies in a variety of formats according to the...
Autores principales: | Chaisri, Urai, Chaicumpa, Wanpen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5994580/ https://www.ncbi.nlm.nih.gov/pubmed/29998138 http://dx.doi.org/10.1155/2018/9747549 |
Ejemplares similares
-
Mouse Model of Cat Allergic Rhinitis and Intranasal Liposome-Adjuvanted Refined Fel d 1 Vaccine
por: Tasaniyananda, Natt, et al.
Publicado: (2016) -
Tregitope-linked Refined Allergen Vaccines for Immunotherapy in Cockroach Allergy
por: Prangtaworn, Pannathee, et al.
Publicado: (2018) -
Engineered Human Monoclonal scFv to Receptor Binding Domain of Ebolavirus
por: Densumite, Jaslan, et al.
Publicado: (2021) -
Comparing Influenza Virus Biology for Understanding Influenza D Virus
por: Skelton, Raegan M., et al.
Publicado: (2022) -
Specific B-cell Epitope of Per a 1: A Major Allergen of American Cockroach (Periplaneta americana) and Anatomical Localization
por: Sookrung, Nitat, et al.
Publicado: (2014)